Trade Summary

3 days ago, Harris Erik, serving as EVP, Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 10,539 shares at $22.80 per share, for a total transaction value of $240,289.00. Following this transaction, Harris Erik now holds 89,515 shares of RARE.

This sale represents a 11.00% decrease in Harris Erik's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Ultragenyx Pharmaceutical Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.